Complaints Policy


Terms of Sale
All products offered for sale by DermatologyAlliance are subject to availability. We reserve the right to limit quantities on any order or decline all or part of an order without prior notice. If an error occurs, we may correct it, adjust your order (including the price), or cancel the order and refund any amounts charged. Product prices are subject to change at any time. You are responsible for any applicable taxes, duties, customs fees, or other governmental charges (“Taxes”) related to your purchase. DermatologyAlliance will collect applicable Taxes when required and will provide an estimate at checkout unless otherwise specified. Actual Taxes charged may vary due to system calculations or changes in tax rates. In certain jurisdictions, you may be required to report and remit taxes directly if we do not collect them.

Only accepted payment methods may be used to complete purchases through our platform. By submitting payment details, you confirm authorization to use your selected payment method. You authorize us to charge the full amount of your order, including applicable taxes, shipping, and handling fees. If your payment method is declined, we will attempt to process the transaction until successful. DermatologyAlliance and its third-party payment processors may receive updated payment details from your card issuer (e.g., updated numbers or expiration dates) and may use such information for future transactions unless you opt out directly with your card issuer. We are not responsible for any fees charged by your bank or card issuer.

If certain items in your order are unavailable, charges will apply only to the shipped items, including applicable Taxes and fees. You may be required to provide transaction-related information such as billing and shipping addresses, contact information, and payment card details. By submitting this information, you authorize DermatologyAlliance and its third-party partners to use it for processing and facilitating the transaction.

All transactions are processed through our third-party payment provider. For details regarding their policies, including privacy and security measures, please refer to their website. DermatologyAlliance maintains a strictly contractual relationship with these vendors, which does not imply agency, partnership, or other fiduciary relationships.

Shipping and handling charges are displayed during checkout and are subject to change at any time, with notice provided before purchase. Delivery timeframes are estimates and are not guaranteed. The risk of loss transfers to the buyer once the order is handed over to the carrier unless otherwise specified.

We address user concerns on a case-by-case basis and reserve the right to resolve issues at our sole discretion, taking the specific circumstances into account.

Termination
DermatologyAlliance reserves the right to terminate your access to the platform, features, or services at any time without prior notice. This may occur due to violations of the Terms, termination of agreements with third-party providers, or service discontinuation. Provisions regarding security, liability, intellectual property, and dispute resolution will remain in effect following termination.

If your access is terminated, you may not attempt to regain access to the platform under any other name or account. Violations of this restriction may result in liability for damages to DermatologyAlliance. Except as required by law or outlined in our Privacy Policy, we are not obligated to return or provide access to any information you submitted to us after termination.

Refunds
Orders must be canceled before processing begins. Subscription cancellations must be made at least seven days prior to renewal. Refunds are not available for orders already in progress.

BOOK AN APPOINTMENT

VISIT OUR OTHER LOCATIONS

KELLER LOCATION

12469 Timberland Blvd #501
Fort Worth, TX 76244

Fax: 817.431.7979

817-431-6555

COPPELL LOCATION

215 South Denton Tap Rd Suite 170 Coppell, TX 75019

Fax: 972.304.6050

469-312-7302

ROANOKE LOCATION

206 Denton Dr
Roanoke, TX 76262

Fax: 682.237.2274

682-237-2271

SPECIAL OFFERS

We accept several insurance providers. Check out the complete list to see if you are covered.

Safety Information

Critical Details About Compounded Semaglutide

Compounded medications are legally allowed to be prescribed under federal law; however, they are not FDA-approved and do not undergo FDA evaluation for safety, efficacy, or production standards. At DermatologyAlliance, compounded semaglutide is prescribed based on an individualized medical assessment.

WARNING: Potential Risk of Thyroid C-Cell Tumors
Research in animals has linked semaglutide, the active ingredient in some GLP-1 receptor agonists, to thyroid tumors, including medullary thyroid carcinoma (MTC). It is unclear if semaglutide causes similar tumors in humans. Notify your healthcare provider immediately if you notice symptoms of thyroid cancer, such as neck lumps or swelling, hoarseness, swallowing difficulties, or shortness of breath. Compounded semaglutide is not suitable for individuals with personal or family histories of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Uses of Compounded Semaglutide
Compounded semaglutide is intended for use alongside a reduced-calorie diet and increased physical activity to manage chronic weight in adults who meet the following criteria:

  • A body mass index (BMI) of 30 kg/m² or higher (classified as obesity), or
  • A BMI of 27 kg/m² or higher (overweight) with at least one weight-related condition, such as type 2 diabetes, hypertension, or abnormal cholesterol levels.

Usage Restrictions

  • Do not use compounded semaglutide in combination with other GLP-1 receptor agonists or semaglutide-containing products.
  • Its safety and effectiveness when combined with other weight management medications have not been established.
  • Patients with a history of pancreatitis or gastroparesis have not been studied for this treatment.

Avoid Use If You:

  • Have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2.
  • Are diagnosed with type 1 diabetes, pancreatitis, or gastroparesis.
  • Are allergic to semaglutide or any inactive ingredients.
  • Have a history of suicidal thoughts or behavior.

Precautions and Warnings:

  • Acute Pancreatitis: Stop using the medication if pancreatitis is suspected.
  • Gallbladder Issues: Monitor for symptoms of gallbladder disease, including gallstones, and seek medical advice as needed.
  • Low Blood Sugar: When combined with insulin or similar medications, there is an increased risk of hypoglycemia. Regularly monitor blood sugar and adjust doses as recommended by your provider.
  • Kidney Health: Monitor kidney function, particularly in patients with renal impairment or those experiencing severe gastrointestinal effects.
  • Mental Health Concerns: Watch for mood changes, depression, or suicidal thoughts, and discontinue use if these symptoms occur.

Pregnancy and Fertility Considerations
Semaglutide may harm an unborn child. Avoid use during pregnancy or if planning to become pregnant. Stop treatment at least two months before attempting to conceive.

Common Side Effects:
Frequently reported side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, headaches, and low blood sugar in patients with type 2 diabetes.

Potential Drug Interactions:
Compounded semaglutide slows gastric emptying, which could impact the absorption of oral medications. Consult your healthcare provider to manage potential interactions effectively.

Medication Disclaimer

Essential Information on Medications: Saxenda®, Victoza®, Wegovy®, and Ozempic® are patented products of Novo Nordisk™, while Eli Lilly and Company™ produce Mounjaro™ and Zepbound. This website is not affiliated with, endorsed by, or connected to these companies or their products in any capacity. While these FDA-approved medications may be available through other sources, we do not provide them, and they are currently experiencing supply shortages. During such shortages, pharmacies might prepare compounded versions of these drugs, provided they comply with the Federal Food, Drug, and Cosmetic Act’s requirements. Compounded medications are valuable for patients with unique medical needs that FDA-approved drugs cannot address. However, it is important to note that compounded drugs are not FDA-approved, nor do they undergo premarketing evaluations for safety, effectiveness, or quality. The FDA has not assessed these medications for their intended uses, nor has the manufacturing process for compounded drugs been reviewed by the FDA.